Chronic Lung Disease of Prematurity Completed Phase 4 Trials for Poractant alfa (DB09113)

Also known as: BPD - Bronchopulmonary Dysplasia / Bronchopulmonary Dysplasia (BPD) / Broncho Pulmonary Dysplasia / Bronchopulmonary Dysplasia / Other chronic respiratory diseases originating in the perinatal period / Bronchopulmonary dysplasia of newborn (disorder)

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01039285Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary DysplasiaTreatment